News

September 17, 2026

Beta Bionics Announces Closing of $172.5 Million Public Offering of Common Stock

September 15, 2026

Beta Bionics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

September 15, 2026

Beta Bionics Announces Proposed Public Offering of $125.0 Million of Common Stock

September 14, 2026

Beta Bionics Announces FDA Clearance of Mint™, the Company’s Transformative Patch Pump, and Unveils 3D Intelligence™ as its Next-Generation Insulin Dosing Algorithm

July 29, 2026

Beta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 Guidance

July 1, 2026

Beta Bionics to Announce Second Quarter 2026 Financial Results on July 29, 2026

June 2, 2026

Beta Bionics First in Automated Insulin Delivery to Publish Near Real-Time Real-World Data on a Public Website

May 21, 2026

Beta Bionics Updates Commercialization Timeline Expectations for Mint™, its Patch Pump in Development

April 27, 2026

Beta Bionics to Present at the Bank of America Securities Health Care Conference

April 21, 2026

Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance